PRC
HRMY icon

Pearl River Capital’s Harmony Biosciences HRMY Stock Holding History

Pearl River Capital’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,624
Closed -$268K – 549
2023
Q2 		$268K Sell
7,624
-1,542
-17% -$53.2K 0.04% 412
2023
Q1 		$299K Sell
9,166
-2,660
-22% -$121K 0.05% 408
2022
Q4 		$652K Buy
11,826
+6,038
+104% +$332K 0.11% 280
2022
Q3 		$256K Buy
5,788
+117
+2% +$5.71K 0.05% 402
2022
Q2 		$277K Buy
5,671
+833
+17% +$37.5K 0.07% 365
2022
Q1 		$235K Buy
+4,838
New +$197K 0.06% 342

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Pearl River Capital's HRMY Position: Q3 2023 in Review

Pearl River Capital sold out of Harmony Biosciences (HRMY) in Q3 2023, closing a stake of 7,624 shares — an estimated $268K sold.

Pearl River Capital first reported a position in HRMY in Q1 2022 and held it in 6 quarters. The position peaked at $652K in Q4 2022. 204 funds tracked by Wall St. Rank hold HRMY as of Q3 2023.

  • Pearl River Capital reported no remaining Harmony Biosciences position as of Q3 2023 after selling out during the quarter.
  • Pearl River Capital sold 7,624 Harmony Biosciences shares in Q3 2023, an estimated $268K.
  • Pearl River Capital first reported a position in Harmony Biosciences in Q1 2022 and held it in 6 quarters.
  • Pearl River Capital's Harmony Biosciences position peaked at $652K in Q4 2022.
  • 204 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2023.

Based on Pearl River Capital's 13F filing for Q3 2023, filed 13 Nov 2023.